Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease
- PMID: 12427781
- PMCID: PMC1773455
- DOI: 10.1136/gut.51.6.808
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease
Abstract
Background and aims: Recent studies on appendicectomy rates in ulcerative colitis and Crohn's disease have generally not addressed the effect of appendicectomy on disease characteristics. The aims of this study were to compare appendicectomy rates in Australian inflammatory bowel disease patients and matched controls, and to evaluate the effect of prior appendicectomy on disease characteristics.
Methods: Patients were ascertained from the Brisbane Inflammatory Bowel Disease database. Controls matched for age and sex were randomly selected from the Australian Twin Registry. Disease characteristics included age at diagnosis, disease site, need for immunosuppression, and intestinal resection.
Results: The study confirmed the significant negative association between appendicectomy and ulcerative colitis (odds ratio (OR) 0.23, 95% confidence interval (CI) 0.14-0.38; p<0.0001) and found a similar result for Crohn's disease once the bias of appendicectomy at diagnosis was addressed (OR 0.34, 95% CI 0.23-0.51; p<0.0001). Prior appendicectomy delayed age of presentation for both diseases and was statistically significant for Crohn's disease (p=0.02). In ulcerative colitis, patients with prior appendicectomy had clinically milder disease with reduced requirement for immunosuppression (OR 0.15, 95% CI 0.02-1.15; p=0.04) and proctocolectomy (p=0.02).
Conclusions: Compared with patients without prior appendicectomy, appendicectomy before diagnosis delays disease onset in ulcerative colitis and Crohn's disease and gives rise to a milder disease phenotype in ulcerative colitis.
Comment in
-
Appendix redux.Gut. 2002 Dec;51(6):764-5. doi: 10.1136/gut.51.6.764. Gut. 2002. PMID: 12427770 Free PMC article. No abstract available.
-
A role for the appendix in inflammatory bowel disease? Cut it out.Gastroenterology. 2003 Oct;125(4):1270-2; discussion 1272. Gastroenterology. 2003. PMID: 15108715 No abstract available.
References
-
- Podolsky DK. Inflammatory bowel disease (1). N Engl J Med 1991;325:928–37. - PubMed
-
- Hanauer SB. Inflammatory bowel disease. N Engl J Med 1996;334:841–8. - PubMed
-
- Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001;411:599–603. - PubMed
-
- Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 2001;411:603–6. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical